Sysmex Corporation (SSMXY)
OTCMKTS · Delayed Price · Currency is USD
12.82
+0.10 (0.79%)
Sep 3, 2025, 9:41 AM EDT
Sysmex Revenue
Sysmex had revenue of 105.73B JPY in the quarter ending June 30, 2025, a decrease of -5.55%. This brings the company's revenue in the last twelve months to 502.43B, up 5.09% year-over-year. In the fiscal year ending March 31, 2025, Sysmex had annual revenue of 508.64B with 10.21% growth.
Revenue (ttm)
502.43B JPY
Revenue Growth
+5.09%
P/S Ratio
2.30
Revenue / Employee
47.70M JPY
Employees
10,533
Market Cap
8.00B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 508.64B | 47.13B | 10.21% |
Mar 31, 2024 | 461.51B | 51.01B | 12.43% |
Mar 31, 2023 | 410.50B | 46.72B | 12.84% |
Mar 31, 2022 | 363.78B | 58.71B | 19.24% |
Mar 31, 2021 | 305.07B | 3.09B | 1.02% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Elite Pharmaceuticals | 105.45M |
Tian'an Technology Group | 2.12M |
Glass House Brands | 221.55M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
Longduoduo Company | 4.99M |
Sysmex News
- 27 days ago - Sysmex Corporation (SSMXY) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Sysmex reports FQ1 results - Seeking Alpha
- 3 months ago - Sysmex GAAP EPS of Yen 86.05, revenue of Yen 508.6B - Seeking Alpha
- 10 months ago - Sysmex GAAP EPS of ¥41.70, revenue of ¥242.48B - Seeking Alpha